HALO logo
halo search icon
Arcturus Therapeutics Holdings, Inc.
Arcturus Therapeutics Holdings, Inc.
ARCT · NAS

Arcturus Therapeutics Holdings, Inc.

US$6.82

Price Arrow0.13 (1.94%)
20/05/2026 04:00:01 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueRecent Price downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Arcturus Therapeutics Holdings, Inc. Overview

ARCT Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About ARCT

icon

Telephone

1.858.900.2660

icon

Address

10628 Science Center Drive, San Diego, CA 92121

Description

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

ARCT Price Chart

Key Stats

Market Cap

US$190.15M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 5.85 - 24.17

Trade Value (12mth)

US$2,099,434.00

1 week

-10.44%

1 month

-24.15%

YTD

7.04%

1 year

-44.94%

All time high

188.72

Key Fundamentals

EPS 3 yr Growth

-779.50%

EBITDA Margin

-107.00%

Operating Cashflow

-$74m

Free Cash Flow Return

-29.70%

ROIC

-26.30%

Interest Coverage

0.00

Quick Ratio

6.60

Other Data

Shares Outstanding (Fully Diluted)

28m

HALO Sector

Healthcare

Next Company Report Date

11-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

ARCT Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
04 March 26
04 March 26

ARCT Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-1.12-3-2.4locklocklock
EPS (Fully Diluted)
$locklocklocklock-1.12-3-2.4locklocklock
Growth
%locklocklocklock-415.8-168.519.9locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Arcturus Therapeutics Holdings, Inc. (ARCT:NAS)?
Halo FAQ
The current share price of Arcturus Therapeutics Holdings, Inc. (ARCT:NAS) is USD$6.82.
What is the 52-week high share price for Arcturus Therapeutics Holdings, Inc. (ARCT:NAS)?
Halo FAQ
The 52-week high share price for Arcturus Therapeutics Holdings, Inc. (ARCT:NAS) is USD$24.17.
What is the 52-week low share price for Arcturus Therapeutics Holdings, Inc. (ARCT:NAS)?
Halo FAQ
The 52-week low share price for Arcturus Therapeutics Holdings, Inc. (ARCT:NAS) is USD$5.85.
What is the dividend yield for Arcturus Therapeutics Holdings, Inc. (ARCT:NAS)?
Halo FAQ
Arcturus Therapeutics Holdings, Inc. (ARCT:NAS) does not pay a dividend.
What was Arcturus Therapeutics Holdings, Inc. (ARCT:NAS) last dividend payment?
Halo FAQ
Arcturus Therapeutics Holdings, Inc. (ARCT:NAS) does not pay a dividend.
What is the franking level for Arcturus Therapeutics Holdings, Inc. (ARCT:NAS)?
Halo FAQ
Arcturus Therapeutics Holdings, Inc. (ARCT:NAS) has a franking level of 0.00%.
In which sector is Arcturus Therapeutics Holdings, Inc. (ARCT:NAS) classified?
Halo FAQ
Arcturus Therapeutics Holdings, Inc. (ARCT:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.